Prosecution Insights
Last updated: October 04, 2026

Zivo Bioscience Inc.

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Zivo Bioscience Inc. currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 3 distinct examiners and 3 distinct art units, indicating a broad spread of examination oversight for the portfolio. The alignment of these matters suggests that each case is receiving individual attention from a different official rather than being grouped under a single reviewer.

The busiest examiner for this company is BOECKELMAN, JACOB A, who is responsible for 1 pending office action. Because the total volume is split equally among the 3 distinct examiners, no single official holds a majority of the current prosecution load. This lack of concentration across the 3 distinct art units may require diverse strategies for responding to the USPTO. Practitioners should note that the assigned examiners may have varying procedural preferences despite working within the same technology area.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
0
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (67%)
0
Medium (0%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (33%)
Multi-statute (no §101)2 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOECKELMAN, JACOB A 1 35.2% +45.6%
DURYEE, ALEXANDER MARSH 1 33.3% +41.6%
XU, QING 1 50.9% +55.2%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17410016 NATURAL FEED COMPOSITION DERIVED FROM FRESH WATER ALGAL CULTURES FOR THE PROMOTION OF ANIMAL GROWTH XU, QING 58d overdue
17587582 MATURATION OF IMMUNE AND METABOLIC PROCESSES VIA ALGAL BIOMASS AND/OR RELATED MATERIAL ADMINISTERED TO ANIMALS DURYEE, ALEXANDER MARSH —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17410016 NATURAL FEED COMPOSITION DERIVED FROM FRESH WATER ALGAL CULTURES FOR THE PROMOTION OF ANIMAL GROWTH XU, QING 58d overdue
18077132 BREVUNDIMONAS SP FOR USE IN DISEASE PREVENTION AND TREATMENT BOECKELMAN, JACOB A —
17587582 MATURATION OF IMMUNE AND METABOLIC PROCESSES VIA ALGAL BIOMASS AND/OR RELATED MATERIAL ADMINISTERED TO ANIMALS DURYEE, ALEXANDER MARSH —

Top Art Units

Art UnitApps
1655 1
1657 1
1656 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18077132 BREVUNDIMONAS SP FOR USE IN DISEASE PREVENTION AND TREATMENT BOECKELMAN, JACOB A 1655 §112Other Final Rejection — Pending Dec 07, 2022
17587582 MATURATION OF IMMUNE AND METABOLIC PROCESSES VIA ALGAL BIOMASS AND/OR RELATED MATERIAL ADMINISTERED TO ANIMALS DURYEE, ALEXANDER MARSH 1657 §103§112 Final Rejection — Pending Jan 28, 2022
17410016 NATURAL FEED COMPOSITION DERIVED FROM FRESH WATER ALGAL CULTURES FOR THE PROMOTION OF ANIMAL GROWTH XU, QING 1656 §103§112 Final Rejection 58d overdue Pending Aug 24, 2021

Managing Zivo Bioscience Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month